Sunshine Biopharma Inc. (SBFM)
NASDAQ: SBFMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 8, 9:36 AM ET
SBFM stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.90M
- Forward P/E
- 0.00
- EPS (TTM)
- -$9.45
- Dividend yield
- None
- 52-week range
- 0.356 – 24.30
- Day range
- 0.4399 – 0.47
- Volume / Avg
- 95.68M / 3.33M
- Beta
- —
- Shares outstanding
- 4.31M
52-week range
SBFM stock today
Sunshine Biopharma (SBFM) is trading at $0.4402 on Oct 8, down 37.11% (-$0.2598), versus the S&P 500's 0.33% decline. Volume was 28.7x the average at 95.68M shares, a sign of unusually heavy trading. At this level, SBFM sits near the bottom of its 52-week range of $0.356 to $24.30: 98.2% below the high and 23.7% above the low.
Sunshine Biopharma has posted a net loss over the last twelve months (EPS of -$9.45), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Sunshine Biopharma
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Sunshine Biopharma peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| PRFXPRF Technologies Ltd. | 0.8777 | -0.27% | $3.07M | vs SBFM |
| SILOSilo Pharma Inc. | 1.43 | -0.69% | $2.94M | vs SBFM |
| XRTXXORTX Therapeutics Inc. | 1.75 | +0.87% | $3.17M | vs SBFM |
| GOVXGeoVax Labs Inc. | 0.281 | -2.90% | $2.84M | vs SBFM |
| APVOAptevo Therapeutics Inc. | 1.77 | -3.80% | $3.20M | vs SBFM |
| REVBRevelation Biosciences Inc. | 0.808 | -2.43% | $3.22M | vs SBFM |
| ONCOOnconetix Inc. | 0.625 | +4.66% | $3.28M | vs SBFM |
| CVKDCadrenal Therapeutics Inc. | 0.92 | -5.38% | $3.28M | vs SBFM |
Indexes, lists and sector
Sunshine Biopharma stock FAQ
What is Sunshine Biopharma's stock price today?
SBFM last traded at $0.4402 as of Oct 8, 9:36 AM EDT, down 37.11% on the day. Prices are delayed at least 15 minutes.
What is the SBFM 52-week high?
The 52-week high for SBFM is $24.30 and the 52-week low is $0.356. The stock is currently 98.2% below its high.